Literature DB >> 33518179

Diagnosis of Polycystic Ovary Syndrome: Which Criteria to Use and When?

Sydney Chang1, Andrea Dunaif2.   

Abstract

Current diagnostic criteria for polycystic ovary syndrome (PCOS) are based on expert opinion. This article reviews the rationale for and the limitations of these criteria as well as which criteria to use and when. The insights provided into PCOS pathogenesis by modern genetic analyses and the promise of objective data mining approaches for biologically relevant disease classification are discussed.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnostic criteria; Disease classification; Hyperandrogenism; PCOS; Polycystic ovary syndrome

Mesh:

Year:  2021        PMID: 33518179      PMCID: PMC7860982          DOI: 10.1016/j.ecl.2020.10.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  59 in total

1.  Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

Authors:  Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

2.  Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, Number 789.

Authors: 
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

3.  Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.

Authors:  Emma Ahlqvist; Petter Storm; Annemari Käräjämäki; Mats Martinell; Mozhgan Dorkhan; Annelie Carlsson; Petter Vikman; Rashmi B Prasad; Dina Mansour Aly; Peter Almgren; Ylva Wessman; Nael Shaat; Peter Spégel; Hindrik Mulder; Eero Lindholm; Olle Melander; Ola Hansson; Ulf Malmqvist; Åke Lernmark; Kaj Lahti; Tom Forsén; Tiinamaija Tuomi; Anders H Rosengren; Leif Groop
Journal:  Lancet Diabetes Endocrinol       Date:  2018-03-05       Impact factor: 32.069

4.  The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.

Authors:  Erica B Johnstone; Mitchell P Rosen; Rebecca Neril; Deborah Trevithick; Barbara Sternfeld; Rosemary Murphy; Carolyne Addauan-Andersen; Daniel McConnell; Renee Reijo Pera; Marcelle I Cedars
Journal:  J Clin Endocrinol Metab       Date:  2010-08-18       Impact factor: 5.958

5.  Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.

Authors:  Ryan G Steward; Lan Lan; Anish A Shah; Jason S Yeh; Thomas M Price; James M Goldfarb; Suheil J Muasher
Journal:  Fertil Steril       Date:  2014-01-23       Impact factor: 7.329

Review 6.  Systemic causes of hair loss.

Authors:  Richard L Lin; Lilit Garibyan; Alexandra B Kimball; Lynn A Drake
Journal:  Ann Med       Date:  2016-05-05       Impact factor: 4.709

7.  Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome.

Authors:  Felix R Day; David A Hinds; Joyce Y Tung; Lisette Stolk; Unnur Styrkarsdottir; Richa Saxena; Andrew Bjonnes; Linda Broer; David B Dunger; Bjarni V Halldorsson; Debbie A Lawlor; Guillaume Laval; Iain Mathieson; Wendy L McCardle; Yvonne Louwers; Cindy Meun; Susan Ring; Robert A Scott; Patrick Sulem; André G Uitterlinden; Nicholas J Wareham; Unnur Thorsteinsdottir; Corrine Welt; Kari Stefansson; Joop S E Laven; Ken K Ong; John R B Perry
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

8.  Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood.

Authors:  Brooke Tata; Nour El Houda Mimouni; Anne-Laure Barbotin; Samuel A Malone; Anne Loyens; Pascal Pigny; Didier Dewailly; Sophie Catteau-Jonard; Inger Sundström-Poromaa; Terhi T Piltonen; Federica Dal Bello; Claudio Medana; Vincent Prevot; Jerome Clasadonte; Paolo Giacobini
Journal:  Nat Med       Date:  2018-05-14       Impact factor: 53.440

Review 9.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.

Authors:  Helena J Teede; Marie L Misso; Michael F Costello; Anuja Dokras; Joop Laven; Lisa Moran; Terhi Piltonen; Robert J Norman
Journal:  Fertil Steril       Date:  2018-07-19       Impact factor: 7.329

10.  Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations.

Authors:  M Geoffrey Hayes; Margrit Urbanek; David A Ehrmann; Loren L Armstrong; Ji Young Lee; Ryan Sisk; Tugce Karaderi; Thomas M Barber; Mark I McCarthy; Stephen Franks; Cecilia M Lindgren; Corrine K Welt; Evanthia Diamanti-Kandarakis; Dimitrios Panidis; Mark O Goodarzi; Ricardo Azziz; Yi Zhang; Roland G James; Michael Olivier; Ahmed H Kissebah; Elisabet Stener-Victorin; Richard S Legro; Andrea Dunaif
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

View more
  6 in total

1.  Developmental Programming: Prenatal Testosterone Excess on Liver and Muscle Coding and Noncoding RNA in Female Sheep.

Authors:  Nadia Saadat; Muraly Puttabyatappa; Venkateswaran R Elangovan; John Dou; Joseph N Ciarelli; Robert C Thompson; Kelly M Bakulski; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 4.736

Review 2.  A Review on CYP11A1, CYP17A1, and CYP19A1 Polymorphism Studies: Candidate Susceptibility Genes for Polycystic Ovary Syndrome (PCOS) and Infertility.

Authors:  Roozbeh Heidarzadehpilehrood; Maryam Pirhoushiaran; Rasoul Abdollahzadeh; Malina Binti Osman; Maryam Sakinah; Norshariza Nordin; Habibah Abdul Hamid
Journal:  Genes (Basel)       Date:  2022-02-05       Impact factor: 4.096

3.  The risk factors of gestational hypertension in patients with polycystic ovary syndrome: a retrospective analysis.

Authors:  Shu Zhou; Yiping Ji; Haimei Wang
Journal:  BMC Pregnancy Childbirth       Date:  2021-04-27       Impact factor: 3.007

Review 4.  microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome.

Authors:  Mona Tamaddon; Mostafa Azimzadeh; Seyed Mohammad Tavangar
Journal:  J Cell Mol Med       Date:  2022-01-06       Impact factor: 5.310

Review 5.  Efficacy of Flavonoids on Animal Models of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Jiacheng Zhang; Haolin Zhang; Xiyan Xin; Yutian Zhu; Yang Ye; Dong Li
Journal:  Nutrients       Date:  2022-10-04       Impact factor: 6.706

6.  Association of Subclinical Hypothyroidism with Present and Absent Anti-Thyroid Antibodies with PCOS Phenotypes and Metabolic Profile.

Authors:  Iwona Magdalena Gawron; Rafał Baran; Kamil Derbisz; Robert Jach
Journal:  J Clin Med       Date:  2022-03-11       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.